Latest
Recommended
Published: Sun, May 13, 2018
Economy | By Melissa Porter

EXACT Sciences (EXAS) Stock Price Up 0% After Better-Than-Expected Earnings


(NYSE:COL). Elk Creek Ltd Liability Corporation invested in 1,671 shares or 0.01% of the stock.

The Best Buy Co., Inc. exchanged hands with 2565157 shares compared to its average daily volume of 3.66M shares.

Exact Sciences Corporation, a molecular diagnostics company, focuses on developing products for the early detection and prevention of various cancers in the United States.The firm is valued at $6.29 billion. EXAS outperformed the S&P 500 by 69.88%.

Highvista Strategies Llc decreased Rockwell Collins Inc (COL) stake by 18.98% reported in 2017Q4 SEC filing.

P/S, P/E, P/C and P/B/ SMA50, SMA 200: The price-to-sales is a valuation ratio that relates a company's stock price to its revenues. The institutional investor held 1.57 million shares of the consumer services company at the end of 2017Q4, valued at $124.49 million, down from 2.37M at the end of the previous reported quarter.

The move comes after 9 months positive chart setup for the $6.29B company. (NYSE:TWX) went up during the trading session by $0.24 on Wednesday, trading at $96.28. About 107,221 shares traded. Abbott Laboratories (NYSE:ABT) has risen 34.85% since April 28, 2017 and is uptrending. It has outperformed by 8.56% the S&P500. On Tuesday, October 31 the stock of Exact Sciences Corporation (NASDAQ:EXAS) has "Buy" rating given by Canaccord Genuity. Therefore 61% are positive. William Blair reiterated a "buy" rating on shares of EXACT Sciences in a report on Tuesday, January 2nd. The rating was maintained by Canaccord Genuity on Monday, March 19 with "Buy". (NASDAQ:EXAS) has 24 ratings reports on April 28, 2018 according to StockzIntelligence. Craig Hallum maintained it with "Buy" rating and $4600 target in Wednesday, July 26 report. The stock has "Buy" rating by Leerink Swann on Monday, November 13. On Tuesday, October 31 the firm earned "Outperform" rating by Leerink Swann. Amer Century Cos Incorporated, Missouri-based fund reported 114,580 shares. The firm has "Buy" rating given on Friday, February 23 by Canaccord Genuity. Seven analysts have rated the stock with a hold rating and six have given a buy rating to the company's stock.

Since January 2, 2018, it had 0 buys, and 20 selling transactions for $24.73 million activity. On Thursday, April 12 Shares for $325,440 were sold by Zanotti Katherine S. Shares for $187,134 were sold by COWARD D SCOTT. Also, CFO Jeffrey Thomas Elliott sold 2,982 shares of the company's stock in a transaction dated Monday, February 26th. 3,098 shares valued at $126,925 were sold by Doyle James Edward on Tuesday, April 10. LIDGARD GRAHAM PETER sold $1.11M worth of stock. Buffington Mohr Mcneal invested in 2.58% or 49,755 shares.

Big Money Sentiment decreased to 0.88 in 2017 Q4. At the moment, the company has a debt-to-equity ratio of 0.84, a current ratio of 1.10, and a quick ratio of 0.90.

BidaskClub upgraded shares of EXACT Sciences (NASDAQ:EXAS) from a hold rating to a buy rating in a research report report published on Friday, April 20th.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. While, the analyst predicted that the company could provide an EPS of $-0.24/share.

The performance of Exact Sciences Corporation (NASDAQ:EXAS), so far this year is at -7.27%. Sandy Spring Financial Bank accumulated 3,110 shs. Shell Asset Mgmt has 0.02% invested in Exact Sciences Corporation (NASDAQ:EXAS). 208,070 were accumulated by Granahan Invest Inc Ma. Vanguard Gp holds 0% of its portfolio in XO Group Inc. Solaris Asset Management Limited Liability Com stated it has 0.05% in Exact Sciences Corporation (NASDAQ:EXAS). Employees Retirement Association Of Colorado invested in 21,389 shares. Alps Advsr Incorporated holds 0% of its portfolio in American Express Company (NYSE:AXP) for 4,881 shares. Amer Rech Mngmt holds 0.02% of its portfolio in Exact Sciences Corporation (NASDAQ:EXAS) for 1,000 shares. C M Bidwell & Associates Ltd. bought a new position in EXACT Sciences during the fourth quarter worth $117,000. Creative Planning invested in 0.01% or 53,306 shs. Its up 0.06, from 0.83 in 2017Q3. (NASDAQ:EXAS) has 75% bullish analysts. 57 funds opened positions while 146 raised stakes. Sei owns 45,445 shs for 0.01% of their capital. Reilly Fincl Advisors Llc stated it has 1.57% of its portfolio in Abbott Laboratories (NYSE:ABT). Summit Grp Lc has 323,500 shares. Doheny Asset Management Ca reported 44,640 shs or 1.09% of all its holdings. 56,575 are held by Ledyard Bancorp. 701.90 million shares or 1.01% less from 709.03 million shares in 2017Q3 were reported. Qs Invsts holds 2,563 shares or 0% of its portfolio. Ibm Retirement Fund has 0.44% invested in Abbott Laboratories (NYSE:ABT). Point72 Asset Management LP owns 546,806 shares. Rmb Capital Limited Company holds 13,665 shares. Winslow Evans & Crocker Inc reported 28,888 shares. (NYSE:COL). Mastrapasqua Asset Management invested 0.24% of its portfolio in Rockwell Collins, Inc. Gofen And Glossberg Ltd Il accumulated 0.02% or 9,000 shares.

On 3/12/2018 Maneesh Arora, COO, sold 5,295 with an average share price of $52.19 per share and the total transaction amounting to $276,346.05. 11,106 Abbott Laboratories (NYSE:ABT) shares with value of $667,804 were sold by Fussell Stephen R. Another trade for 996 shares valued at $58,635 was made by Watkin Jared on Wednesday, February 28.

Among 25 analysts covering Abbott Laboratories (NYSE:ABT), 18 have Buy rating, 0 Sell and 7 Hold. Barclays Capital maintained the shares of ABT in report on Thursday, April 20 with "Overweight" rating. A Beta component of the stock stands at 0.92. The rating was downgraded by Benchmark to "Hold" on Friday, February 23. Roth Capital maintained the stock with "Hold" rating in Tuesday, October 31 report. If the answer is greater than 1, it indicates that the price of the stock is in gaining momentum. BMO Capital Markets maintained it with "Market Perform" rating and $5 target in Thursday, October 19 report. On Friday, July 24 the stock rating was upgraded by Lake Street to "Buy".

Like this: